Search
EHA donates €250,000 to Médecins Sans Frontières
The EHA Board is actively implementing support actions to hematologists and hematology patients in Ukraine and to those who are forced to leave the country.
Read moreFP9 recommendations BioMed Alliance
With preparations under way for the EU’s next Framework Programme for Research and Innovation (FP9), the BioMed Alliance has called for more robust EU support for health research.
Read moreResearch Committee
Current committee members
Brian Huntly, United Kingdom (Chair)
Ruud Delwel, The Netherlands (Vice-Chair)
Dominique Bonnet, United Kingdom (EHA Board representative)
Shai Izraeli, Israel (TRTH representative)
David Kent, United Kingdom (Fellowships and Grants representative)
Alba Maiques Diaz, Spain (YoungEHA representative)
Martina Muckenthaler, Germany (HemaSphere representative)
Andreas Trumpp, Germany (Supernumerary…
Novel basis for chemoresistance in AML: DNMT3A R882 mutations promote chemoresistance and residual disease through impaired DNA damage sensing
Although most acute myeloid leukemia (AML) patients initially respond to chemotherapy, the majority subsequently relapses and succumbs to refractory disease. Residual leukemic cells that survived chemotherapy may persist over time and later cause the disease to come back.
Read moreCurriculum-Exam Committee
Current committee members
Jose Tomás Navarro Ferrando, Spain (Chair)
Marielle Wondergem, The Netherlands (Vice-Chair)
Alicia Rovó, Switzerland (National Society representative)
Regular members
Gunnar Birgegård, Sweden
Janaki Brolin, Sweden
Carlos Fernández de Larrea, Spain
Mahesh Prahladan, United Kingdom
AimTo promote harmonization in hematology training and education in Europe and beyond…
Cancer Medicines Forum workshop April 5: a way forward for treatment optimization
The Cancer Medicines Forum (CMF) is hosted by the European Medicines Agency (EMA) in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC).
Read moreEHA-Balkan Hematology Day 2023
EHA is joining forces with the national societies from the Balkan countries and co-organizing with them the 4th edition of the EHA-Balkan Hematology Day.
Read moreEHA-ASH Translational Research Training in Hematology
TRTH 2025 call is now closed. What is Translational Research Training in Hematology?
Translational Research Training in Hematology (TRTH) provides early-career researchers with a unique, year-long training and mentoring experience.
- «
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- »